Search - tctmd.com

Displaying 661 - 680 of 3032

Sort: Relevancy | Date

Presentation TCT 2022

Strengths and Limitations of Patient Reported Outcomes as Major Endpoints in "Modern Era" CV Trials

Presenter: Alexander Iribarne

September 19, 2022

Presentation TCT 2022

Cardiogenic Shock Trials: Defining the Clinical Need and Framing the Issues

Presenter: Navin Kapur

September 19, 2022

Presentation TCT 2022

Transformative Changes in Clinical Research: A Futurist’s Viewpoint

Presenter: C. Michael Gibson

September 18, 2022

Presentation TCT 2022

Health Equity Issues in Clinical Trials: Can We Accelerate Progress?

Presenter: Clyde Yancy

September 18, 2022

Presentation TCT 2022

Regulatory Innovation Revisited: Blending Patient Needs, Industry Imperatives, Health Policy, and Reimbursement

Presenter: Aaron Kaplan

September 18, 2022

Presentation TCT 2022

FDA Recovering From a Pandemic: Lessons Learned and Future Adjustments

Presenter: William Maisel

September 18, 2022

News Conference News TCT 2022

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

Todd Neale

September 18, 2022

Presentation TCT 2022

Current FDA-Approved Devices: How to Select; Lesion-Specific Differences

Presenter: Reda Ibrahim

September 18, 2022

News Conference News TCT 2022

To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf

L.A. McKeown

September 18, 2022

Presentation TCT 2022

FDA Update on EFS Requirements for TTVR Technologies

Presenter: Kevin G. Soucy

September 17, 2022

News Industry News

NIH - Sponsored Trial of Pharmaco-mechanical Thrombolysis with the BASHIRTM Endovascular Catheter Demonstrates Unprecedented Reduction in Pulmonary Artery Obstruction in Patients with Acute Pulmonary Embolism

September 16, 2022

News Daily News

FDA Approves Pascal TEER Device for Degenerative MR

Shelley Wood

September 15, 2022

News Industry News

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

September 13, 2022

News Daily News

FDA, Abbott Warn of Potential MitraClip Locking Malfunctions

L.A. McKeown

September 09, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Daily News

Watchman FLX Gets DAPT Option Added to Label

Todd Neale

September 06, 2022

News Daily News

Steep Rise in PVAD Support for Protected PCI: Medicare Data

Caitlin E. Cox

August 19, 2022

News Daily News

FDA: Class I Recall of Cobalt and Crome ICDs and CRT-Ds Due to Reduced-Energy Shock

L.A. McKeown

August 19, 2022

News Daily News

VTE Risk Higher With COVID-19 Than With Flu

Todd Neale

August 18, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

Advertisement

Strengths and Limitations of Patient Reported Outcomes as Major Endpoints in "Modern Era" CV Trials

Cardiogenic Shock Trials: Defining the Clinical Need and Framing the Issues

Transformative Changes in Clinical Research: A Futurist’s Viewpoint

Health Equity Issues in Clinical Trials: Can We Accelerate Progress?

Regulatory Innovation Revisited: Blending Patient Needs, Industry Imperatives, Health Policy, and Reimbursement

FDA Recovering From a Pandemic: Lessons Learned and Future Adjustments

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

Current FDA-Approved Devices: How to Select; Lesion-Specific Differences

To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf

FDA Update on EFS Requirements for TTVR Technologies

NIH - Sponsored Trial of Pharmaco-mechanical Thrombolysis with the BASHIRTM Endovascular Catheter Demonstrates Unprecedented Reduction in Pulmonary Artery Obstruction in Patients with Acute Pulmonary Embolism

FDA Approves Pascal TEER Device for Degenerative MR

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

FDA, Abbott Warn of Potential MitraClip Locking Malfunctions

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Watchman FLX Gets DAPT Option Added to Label

Steep Rise in PVAD Support for Protected PCI: Medicare Data

FDA: Class I Recall of Cobalt and Crome ICDs and CRT-Ds Due to Reduced-Energy Shock

VTE Risk Higher With COVID-19 Than With Flu

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content